Grow your business safely with CL PHARMA

All the information you need about CL PHARMA to develop and secure your business in France

C HOME > CORPORATES > CL PHARMA > BALANCE SHEET ( 2022-01-21)

THE LIST OF BALANCE SHEET : CL PHARMA

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-11-24 Partially confidential 2022-03-31 Complete
2022-01-21 Partially confidential 2021-03-31 Complete
NameCL PHARMA
Siren884949991
Closing2021-03-31
Registry code 6852
Registration number 960
Management number2020D00604
Activity code 6430Z
Closing date n-11901-01-01
Duration Fiscal year 09
Duration Fiscal year n-100
Filing date2022-01-21
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPartially confidential
Address68210 DANNEMARIE
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AB Establishment Expenses 6 001.00 829.00 5 172.00 6 001.00
BJ TOTAL (I) 1 828 401.00 829.00 1 827 572.00 1 828 401.00
CF Cash and cash equivalents 1 150.00 1 150.00 1 150.00
CJ TOTAL (II) 1 150.00 1 150.00 1 150.00
CO Grand total (0 to V) 1 829 551.00 829.00 1 828 722.00 1 829 551.00
CU Other investments 1 822 400.00 1 822 400.00 1 822 400.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 647 400.00 647 400.00
DI RESULTS FOR THE YEAR (Profit or Loss) -7 278.00 -7 278.00
DL TOTAL (I) 640 122.00 640 122.00
DU Loans and Debts from Credit Institutions (3) 1 172 000.00 1 172 000.00
DV Miscellaneous Loans and Financial Debts (4) 16 600.00 16 600.00
EC TOTAL (IV) 1 188 600.00 1 188 600.00
EE Grand total (I to V) 1 828 722.00 1 828 722.00
EG Accrued income and payables due within one year 24 199.00 24 199.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 1 828 401.00
CZ ACQUISITIONS: Establishment, Development, or Research Expenses 6 001.00
I3 DECREASES Total Financial Fixed Assets 1 822 400.00
I4 DECREASES Grand Total 1 828 401.00
IN DECREASES Start-up, development, or research expenses 6 001.00
LQ ACQUISITIONS Total Financial Fixed Assets 1 822 400.00
6 - Depreciation Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
0N DEPRECIATION Grand Total 829.00
CY DEPRECIATION Start-up, development, or research expenses 829.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
VH Loans with a maturity of more than one year at origin 1 172 000.00 24 199.00 296 702.00 1 172 000.00
VI Group and Associates 16 600.00 16 600.00
VJ Loans taken out during the year 1 172 000.00 1 172 000.00
VY TOTAL – STATEMENT OF LIABILITIES 1 188 600.00 24 199.00 296 702.00 1 188 600.00
11 - Earnings appropriation & miscellaneous informationAmount for year NAmount for year N-1Amount 1 to 5 yearsAmount more than 5 years
ST Other accounts 525.00 525.00
ZJ Total of the item corresponding to line FW of table no. 2052 525.00 525.00

all companies in France

Complete and comprehensive database.